GlassScriptPhysician profile
Evelyn Li
NPI 1235142761
$6,202.02
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $101 · 2021: $390 · 2022: $61.35 · 2023: $288 · 2024: $5,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,077 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,076.93 |
| Food and Beverage | $363.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,534.61 | 2021-2024 | Reveal Linq, Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.77 | 2019-2021 | |
| Electromed, INC. | $88.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $66.43 | 2019-2021 | |
| Medtronic Vascular, INC. | $55.74 | 2020 | |
| Pfizer INC. | $49.71 | 2019-2021 | |
| Amgen INC. | $48.06 | 2019-2023 | Repatha |
| Silk Road Medical, INC. | $32.99 | 2021 | |
| Gilead Sciences, INC. | $30.04 | 2019 | |
| Becton, Dickinson and Company | $28.52 | 2024 | Venclose Maven Catheter |
| Irhythm Technologies, INC. | $22.80 | 2022 | |
| Atricure, INC. | $21.80 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $18.62 | 2024 | |
| Biocompatibles, INC. | $18.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.